BIOPORTO DIAGNOSTICS A/S: Financial statements 2022
CVR: 18645882
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 28,969,229 and a net result of DKK -81,772,343 compared with DKK -54,122,850 the year before. That is an increase of 19.4% compared with the year before. The profit margin was -282.3%. Equity in the 2022 report amounted to DKK -540,521,321. The company had 20 employees in the financial year.
- Revenue
- DKK 28,969,229
- Gross Profit
- DKK -13,193,070
- Profit/Loss
- DKK -81,772,343
- Equity
- DKK -540,521,321
- Total Assets
- DKK 12,784,777
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 29M | -13.2M | -81.8M | -540.5M | 20 |
| 2021 | 24.3M | -15.2M | -54.1M | -458.7M | 15 |
| 2020 | 23.2M | -10.6M | -42.6M | -404.6M | 16 |
| 2019 | 26.6M | -6.9M | -67.3M | -362M | 17 |
| 2018 | 25.9M | -417K | -43.7M | -294.7M | 17 |
Official annual report
Keep an eye on BIOPORTO DIAGNOSTICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 9, 2022, Jan Leth Christensen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of November 9, 2022, Peter Mørch Eriksen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of November 9, 2022, John Patrick McDonough has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2021. Revenue came to DKK 24,253,658, and the net result was DKK -54,122,850.
As of June 30, 2022, John Patrick McDonough has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of June 30, 2022, Henrik Clausen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 12, 2022, Henrik Clausen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 12, 2022, Anthony Paul Pare has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 12, 2022, Neil Allan Goldman has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 12, 2022, Thomas Magnussen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 28 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.